Switch theme
Sign up to access all valuation multiples
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
2015
1.3K+
LTM Revenue $974M
LTM EBITDA $23.1M
$964M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
NeueHealth has a last 12-month revenue of $974M and a last 12-month EBITDA of $23.1M.
In the most recent fiscal year, NeueHealth achieved revenue of $1.2B and an EBITDA of -$567M.
NeueHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See NeueHealth valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.2B | $958M | XXX | XXX | XXX |
| Gross Profit | $75.7M | $206M | XXX | XXX | XXX |
| Gross Margin | 7% | 21% | XXX | XXX | XXX |
| EBITDA | -$567M | $19.5M | XXX | XXX | XXX |
| EBITDA Margin | -49% | 2% | XXX | XXX | XXX |
| Net Profit | -$1.2B | -$1.5B | XXX | XXX | XXX |
| Net Margin | -102% | -152% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 14, 2025, NeueHealth's stock price is $5.
NeueHealth has current market cap of $42.1M, and EV of $964M.
See NeueHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $964M | $42.1M | XXX | XXX | XXX | XXX | $-17.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 14, 2025, NeueHealth has market cap of $42.1M and EV of $964M.
NeueHealth's trades at 1.0x LTM EV/Revenue multiple, and 41.8x LTM EBITDA.
Analysts estimate NeueHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for NeueHealth and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $964M | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 49.4x | XXX | XXX | XXX |
| P/E | -0.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNeueHealth's NTM/LTM revenue growth is 8%
NeueHealth's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, NeueHealth's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate NeueHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for NeueHealth and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -17% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -103% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 10% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.9M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 26% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Genesis Fertility Center | XXX | XXX | XXX | XXX | XXX | XXX |
| Dc Healthcare Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Health Italia | XXX | XXX | XXX | XXX | XXX | XXX |
| Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Clover Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NeueHealth acquired XXX companies to date.
Last acquisition by NeueHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . NeueHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was NeueHealth founded? | NeueHealth was founded in 2015. |
| Where is NeueHealth headquartered? | NeueHealth is headquartered in United States of America. |
| How many employees does NeueHealth have? | As of today, NeueHealth has 1.3K+ employees. |
| Who is the CEO of NeueHealth? | NeueHealth's CEO is Mr. G. Mike Mikan. |
| Is NeueHealth publicy listed? | Yes, NeueHealth is a public company listed on NYS. |
| What is the stock symbol of NeueHealth? | NeueHealth trades under NEUE ticker. |
| When did NeueHealth go public? | NeueHealth went public in 2021. |
| Who are competitors of NeueHealth? | Similar companies to NeueHealth include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare. |
| What is the current market cap of NeueHealth? | NeueHealth's current market cap is $42.1M |
| What is the current revenue of NeueHealth? | NeueHealth's last 12-month revenue is $974M. |
| What is the current EBITDA of NeueHealth? | NeueHealth's last 12-month EBITDA is $23.1M. |
| What is the current EV/Revenue multiple of NeueHealth? | Current revenue multiple of NeueHealth is 1.0x. |
| What is the current EV/EBITDA multiple of NeueHealth? | Current EBITDA multiple of NeueHealth is 41.8x. |
| What is the current revenue growth of NeueHealth? | NeueHealth revenue growth between 2023 and 2024 was -17%. |
| Is NeueHealth profitable? | Yes, NeueHealth is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
